Z-1444-2020 Class II Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-1444-2020 was initiated by Roche Diagnostics Operations, Inc. on February 7, 2020 and is designated Class II. Reason for recall: The firm has received an increased number of complaints concerning non-reproducible elevated results ("high flyers") for one lot of Elecsys CA 19-9 reagent, which may affect clinical interpretation. The recall status is terminated (terminated May 30, 2024). Affected quantity: 684.

Recall Details

Product Type
Devices
Report Date
March 11, 2020
Initiation Date
February 7, 2020
Termination Date
May 30, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
684

Product Description

Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancer

Reason for Recall

The firm has received an increased number of complaints concerning non-reproducible elevated results ("high flyers") for one lot of Elecsys CA 19-9 reagent, which may affect clinical interpretation.

Distribution Pattern

US Nationwide distribution in the states of AL, AZ, CA, CO, FL, HI, IL, IN, KS, KY, MA, ME, MI, NC, NH, NJ, NY, TN, TX, WA and WI.

Code Information

Lot 416245 ***Updated 10/5/20*** 483123 ***Updated 8/5/22*** Additional released lots are subject to the same workaround: 46449, 50474,525510, and 568976